Serum CHI3L1 Levels Predict Overall Survival of Hepatocellular Carcinoma Patients after Hepatectomy
Journal of Cancer · 2024 · 15 (19) · 6315-6325
DOI: 10.7150/jca.100791 ↗At a glance
Journal article in Journal of Cancer, 2024. Written by Yanji Jiang and 9 co-authors. Institution: Department of Epidemiology and Health Statistics, School of Public Health, Guangxi Medical University, Nanning, Guangxi, 530021, China. Cited 6 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Objective
The Chitinase 3-like protein 1 (CHI3L1) is currently used as a biomarker for the diagnosis of liver fibrosis. However, its prognostic value for hepatocellular carcinoma (HCC) patients remains controversial. In this study, we aimed to investigate the prognostic value of the CHI3L1 in HCC patients after hepatectomy.
Methods
In total, 753 HCC patients who underwent curative hepatectomy between January 2017 to August 2021 were retrospectively recruited. The probability of overall survival (OS) was evaluated by the Kaplan-Meier method and compared between groups using the log-rank test. Cox proportional hazard regression analysis was used to determine the independent prognostic factors. A prognostic nomogram was constructed for further examine the clinical utility of CHI3L1 in HCC.
Results
Kaplan-Meier analysis revealed that elevated serum CHI3L1 levels were associated with worse overall survival of HCC patients. Multivariate Cox regression analysis showed that the high-CHI3L1 group (≥198.94 ng/ml) was associated with a shorter survival time compared with that in the low-CHI3L1 group (< 198.94 ng/ml) after adjustment for potential confounding factors (HR =1.43, 95% CI = 1.05-1.94, P = 0.024). Additionally, the nomogram had sufficient calibration and discriminatory power in the training cohort, with C-indexes of 0.723 (95% CI: 0.673-0.772). The validation cohort showed similar results. Finally, we demonstrated that the AUC of the nomogram was 0.752 (95% CI: 0.683-0.821), which had better predictive ability than AFP (AUC: 0.644, 95% CI: 0.577-0.711).
Conclusion
Our results confirmed that the CHI3L1 could serve as an independent predictor for OS in HCC patients after hepatectomy. The nomogram showed a good performance in prognosis prediction of HCC.
Subjects
Author keywords
Authors and institutions
- Department of Epidemiology and Health Statistics, School of Public Health, Guangxi Medical University, Nanning, Guangxi, 530021, China.
- Department of Scientific Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, China.
- Hepatobiliary Surgery Department, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, China.
- Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, China.
- Department of Cancer Prevention and Control, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, China.
- Department of Disease Process Management, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, China.
Cite
APA
Jiang, Y., Gong, W., Liu, Y., Zhou, Z., Liang, X., Lin, Q., Qiu, M., Lin, B., Qiu, X., & Yu, H. (2024). Serum CHI3L1 Levels Predict Overall Survival of Hepatocellular Carcinoma Patients after Hepatectomy. Journal of Cancer, 15(19), 6315-6325. https://doi.org/10.7150/jca.100791
Vancouver
Jiang Y, Gong W, Liu Y, Zhou Z, Liang X, Lin Q, et al. Serum CHI3L1 Levels Predict Overall Survival of Hepatocellular Carcinoma Patients after Hepatectomy. Journal of Cancer. 2024;15(19):6315-6325. doi:10.7150/jca.100791
BibTeX
@article{Jiang2024,
author = {Jiang, Yanji and Gong, Wenfeng and Liu, Yingchun and Zhou, Zihan and Liang, Xiumei and Lin, Qiuling and Qiu, Moqin and Lin, Biaoyang and Qiu, Xiaoqiang and Yu, Hongping},
title = {Serum CHI3L1 Levels Predict Overall Survival of Hepatocellular Carcinoma Patients after Hepatectomy},
journal = {Journal of Cancer},
year = {2024},
volume = {15},
number = {19},
pages = {6315--6325},
doi = {10.7150/jca.100791}
}
EUVIMED